Submit your image related to Diseases to be featured!

Get Social

Submit your Twitter account related to Childhood Acute Lymphoblastic Leukemia In Remission to be featured!

Blogs

Submit your blog on Childhood Acute Lymphoblastic Leukemia In Remission to be featured!

Events

Submit your event on Childhood Acute Lymphoblastic Leukemia In Remission to be featured!

Videos

Submit your video on Childhood Acute Lymphoblastic Leukemia In Remission to be featured!

Charities

Submit your charity on Childhood Acute Lymphoblastic Leukemia In Remission to be featured!

Childhood Acute Lymphoblastic Leukemia In Remission: Disease Bioinformatics

Childhood Acute Lymphoblastic Leukemia is a fast growing type of blood cancer. The cancer is characterized by the high levels of lymphoblasts in both the blood and bone marrow. The cancer can then spread to other organs in the body and without treatment Childhood Acute Lymphoblastic Leukemia will progress very quickly. Childhood Acute Lymphoblastic Leukemia may arise from transformation of B or T cell progenitor cells. Once there are no traces of leukemia in the body through a series of tests the patient is considered to be in remissiom. Although it is not garunteed that the leukemia witll continue to be in remission, often a petient will go through a relapse where the cancer returns.

Childhood Acute Lymphoblastic Leukemia In Remission Bioinformatics Tool

Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Childhood Acute Lymphoblastic Leukemia In Remission below! For more information on how to use Laverne, please read the How to Guide.
Vizit™, under license from BioVista Inc.

Top Research Reagents

We have 473 products for the study of Childhood Acute Lymphoblastic Leukemia In Remission that can be applied to Flow Cytometry, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.

NBP2-38895
Western Blot: CD21 Antibody [NBP2-38895] - Lane 1: Marker  [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10.  Lane 2: Human cell line RT-4.  Lane 3: Human cell line U-251MG.  Lane 4: Human Plasma.  Lane 5: Human liver tissue.  Lane 6: Human tonsil tissueImmunocytochemistry/Immunofluorescence: CD21 Antibody [NBP2-38895] - Staining of human lymph node shows strong membranous positivity in germinal center cells.

Rabbit Polyclonal
Species Human
Applications WB, ICC/IF, IHC

1 Publication
AF1049
Cathepsin A/Lysosomal Carboxypeptidase A was detected in immersion fixed paraffin-embedded sections of human prostate using Goat Anti-Human Cathepsin A/Lysosomal Carboxypeptidase A Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1049) at 3 µg/mL overnight at 4 °C. Before incubation with the primary antibody, tissue was subjected to heat-induced epitope retrieval using Antigen Retrieval Reagent-Basic (Catalog # <A class=NoLineLink href=

Goat Polyclonal
Species Human
Applications WB, IHC

     1 Review

2 Publications
NBP1-92172
Western Blot: NDUFB6 Antibody [NBP1-92172] - Lane 1: Marker  [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10.  Lane 2: Human cell line RT-4.  Lane 3: Human cell line U-251MG sp.  Lane 4: Human plasma (IgG/HSA depleted).  Lane 5: Human liver tissue.  Lane 6: Human tonsil tissueImmunocytochemistry/Immunofluorescence: NDUFB6 Antibody [NBP1-92172] - Immunofluorescent staining of human cell line A-431 shows localization to nucleoplasm & mitochondria.

Rabbit Polyclonal
Species Human
Applications WB, ICC/IF, IHC

1 Publication
NBP2-29460
Immunohistochemistry-Paraffin: CD35 Antibody (E11) [NBP2-29460] - Hhuman Tonsil stained with CD35 Antibody (E11).Immunohistochemistry-Paraffin: CD35 Antibody (E11) [NBP2-29460] - Formalin-fixed, paraffin-embedded human tonsil stained with CD35 antibody at 1:200 using peroxidase-conjugate and DAB chromogen. Note membrane staining.

Mouse Monoclonal
Species Human, Monkey
Applications WB, ELISA, Flow

5 Publications

Related Genes

Childhood Acute Lymphoblastic Leukemia In Remission has been researched against:

Related Diseases

Childhood Acute Lymphoblastic Leukemia In Remission has been studied in relation to diseases such as:

Alternate Names

Childhood Acute Lymphoblastic Leukemia In Remission is also known as Childhood All In Remission.